Cytomegalovirus antibody elevation in bipolar disorder: Relation to elevated mood states

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Prossin, A R ^a,b   Yolken, R H ^c   Kamali, M ^d   Heitzeg, M M ^d   Kaplow, J B ^a   Coryell, W H ^e   McInnis, M G ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CYTOMEGALOVIRUS ANTIBODY; HERPES SIMPLEX VIRUS 1 ANTIBODY; HERPES SIMPLEX VIRUS 2 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LAMOTRIGINE; LITHIUM; UNCLASSIFIED DRUG; VALPROIC ACID; VIRUS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DEPRESSION; FEMALE; HERPESVIRIDAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PHENOTYPE; SEX DIFFERENCE; AFFECT; BIPOLAR DISORDER; BLOOD; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ADULT; AFFECT; ANTIBODIES, VIRAL; BIPOLAR DISORDER; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE;

EID: 84930656994     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/939780     Document Type: Article

References (51)

1. K. R. Merikangas, H. S. Akiskal, J. Angst et al., "Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication", Archives of General Psychiatry, vol. 64, no. 5, pp. 543-552, 2007.
2. K. R. Merikangas, R. Jin, J.-P. He et al., "Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative", Archives of General Psychiatry, vol. 68, no. 3, pp. 241-251, 2011.
3. A. Schmitt, B. Malchow, A. Hasan, and P. Falkai, "The impact of environmental factors in severe psychiatric disorders", Frontiers in Neuroscience, no. 8, article 19, 2014.
4. S. E. Keller, J. M. Weiss, S. J. Schleifer, N. E. Miller, and M. Stein, "Stress-induced suppression of immunity in adrenalectomized rats", Science, vol. 221, no. 4617, pp. 1301-1304, 1983.
5. S. Prösch, C. E. C. Wendt, P. Reinke et al., "Anovel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMVactivation", Virology, vol. 272, no. 2, pp. 357-365, 2000.
6. S. J. Schleifer, S. E. Keller, M. Camerino, J. C. Thornton, and M. Stein, "Suppression of lymphocyte stimulation following bereavement", The Journal of the American Medical Association, vol. 250, no. 3, pp. 374-377, 1983.
7. J. Jelinek, I. Adkins, Z. Mikulkova et al., "In vitro activation of CMV-specific human CD8+ T cells by adenylate cyclase toxoids delivering pp65 epitopes", Bone Marrow Transplantation, vol. 47, no. 2, pp. 243-250, 2012.
8. D. Barzman, J. Eliassen, R. McNamara et al., "Correlations of inflammatory gene pathways, corticolimbic functional activities, and aggression in pediatric bipolar disorder: a preliminary study", Psychiatry Research, vol. 224, no. 2, pp. 107-111, 2014.
9. I. G. Barbosa, C. R. C. Nogueira, N. P. Rocha et al., "Altered intracellular signaling cascades in peripheral blood mononuclear cells fromBD patients", Journal of Psychiatric Research, vol. 47, no. 12, pp. 1949-1954, 2013.
10. S. M. O'Brien, P. Scully, L. V. Scott, and T. G. Dinan, "Cytokine profiles in bipolar affective disorder: focus on acutely ill patients", Journal of Affective Disorders, vol. 90, no. 2-3, pp. 263-267, 2006.
11. E. Brietzke and F. Kapczinski, "TNF-α as a molecular target in bipolar disorder", Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 6, pp. 1355-1361, 2008.
12. F. B. Dickerson, J. J. Boronow, C. Stallings et al., "Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder", Biological Psychiatry, vol. 55, no. 6, pp. 588-593, 2004.
13. M. M. Prossin A, A. Anand, M. Heitzeg, and J.-K. Zubieta, "Tackling the Kraepelinian Dichotomy: a neuroimaging review", Psychiatric Annals, vol. 40, pp. 162-167, 2010.
14. J. J. Kim, B. H. Shirts, M. Dayal et al., "Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?" Annals of Medicine, vol. 39, no. 2, pp. 145-153, 2007.
15. F. M. Leweke, C. W. Gerth, D. Koethe et al., "Antibodies to infectious agents in individuals with recent onset schizophrenia", European Archives of Psychiatry and Clinical Neuroscience, vol. 254, no. 1, pp. 4-8, 2004.
16. B. H. Shirts, J. J. Kim, S. Reich et al., "Polymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia risk", Schizophrenia Research, vol. 94, no. 1-3, pp. 342-353, 2007.
17. B. H. Shirts, K. M. Prasad, M. F. Pogue-Geile, F. Dickerson, R. H. Yolken, and V. L. Nimgaonkar, "Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia", Schizophrenia Research, vol. 106, no. 2-3, pp. 268-274, 2008.
18. E. F. Torrey, M. F. Leweke, M. J. Schwarz et al., "Cytomegalovirus and schizophrenia", CNS Drugs, vol. 20, no. 11, pp. 879-885, 2006.
19. R. S. Lazarus, "From psychological stress to the emotions: a history of changing outlooks", Annual Review of Psychology, vol. 44, no. 1, pp. 1-21, 1993.
20. A. Caspi and T. E. Moffitt, "Gene-environment interactions in psychiatry: joining forces with neuroscience", Nature Reviews Neuroscience, vol. 7, no. 7, pp. 583-590, 2006.
21. T. E. Moffitt, A. Caspi, and M. Rutter, "Strategy for investigating interactions between measured genes and measured environments", Archives of General Psychiatry, vol. 62, no. 5, pp. 473-481, 2005.
22. C. L. Ehlers, E. Frank, and D. J. Kupfer, "Social zeitgebers and biological rhythms: a unified approach to understanding the etiology of depression", Archives of General Psychiatry, vol. 45, no. 10, pp. 948-952, 1988.
23. H. A. Swartz, E. Frank, K. O'Toole et al., "Implementing interpersonal and social rhythm therapy for mood disorders across a continuum of care", Psychiatric Services, vol. 62, no. 11, pp. 1377-1380, 2011.
24. D.-I. Apatfo, Diagnostic and Statistical Manual of Mental Disorders, text revision, New York, NY, USA, 4th edition, 2000.
25. J. I. Nurnberger Jr., M. C. Blehar, C. A. Kaufmann et al., "Diagnostic interview for genetic studies: rationale, unique features, and training", Archives of General Psychiatry, vol. 51, no. 11, pp. 849-859, 1994.
26. M. Hamilton, "Development of a rating scale for primary depressive illness", British Journal of Social and Clinical Psychology, vol. 6, no. 4, pp. 278-296, 1967.
27. R. C. Young, J. T. Biggs, V. E. Ziegler, and D. A. Meyer, "A rating scale for mania: reliability, validity and sensitivity", The British Journal of Psychiatry, vol. 133, no. 11, pp. 429-435, 1978.
28. F. B. Dickerson, J. J. Boronow, C. R. Stallings, A. E. Origoni, and R. H. Yolken, "Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia", The American Journal of Psychiatry, vol. 160, no. 12, pp. 2234-2236, 2003.
29. C. E. Bonferroni, "Teoria statistica delle classi e calcolo delle probabilità", Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze, vol. 8, pp. 3-62, 1936.
30. P. B. Mortensen, C. B. Pedersen, J. J. Mcgrath et al., "Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study", Bipolar Disorders, vol. 13, no. 7-8, pp. 624-629, 2011.
31. S. L. Bate, S. C. Dollard, and M. J. Cannon, "Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988.2004", Clinical Infectious Diseases, vol. 50, no. 11, pp. 1439-1447, 2010.
32. P. Moss and N. Khan, "CD8+ T-cell immunity to cytomegalovirus", Human Immunology, vol. 65, no. 5, pp. 456-464, 2004.
33. T. Crough and R. Khanna, "Immimobiology of human cytomegalovirus: from bench to bedside", Clinical Microbiology Reviews, vol. 22, no. 1, pp. 76-98, 2009.
34. M. T. Caserta, T. G. O'Connor, P. A. Wyman et al., "The associations between psychosocial stress and the frequency of illness, and innate and adaptive immune function in children", Brain, Behavior, and Immunity, vol. 22, no. 6, pp. 933-940, 2008.
35. R. Glaser and J. Kiecolt-Glaser, "How stress damages immune system and health", Discovery Medicine, vol. 5, no. 26, pp. 165-169, 2005.
36. R. Glaser, B. Rabin, M. Chesney, S. Cohen, and B. Natelson, "Stress-induced immunomodulation: implications for infectious diseases?" The Journal of the American Medical Association, vol. 281, no. 24, pp. 2268-2270, 1999.
37. R. Glaser, S. B. Friedman, J. Smyth et al., "Thedifferential impact of training stress and final examination stress on herpesvirus latency at the United States Military Academy at West Point", Brain, Behavior, and Immunity, vol. 13, no. 3, pp. 240-251, 1999.
38. Y. J. Tang-Feldman, G. R. Lochhead, S. R. Lochhead, C. Yu, and C. Pomeroy, "Interleukin-10 repletion suppresses proinflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV) - infected IL-10 knockout mice", Inflammation Research, vol. 60, no. 3, pp. 233-243, 2011.
39. S. Varani, G. Rossini, A. Mastroianni et al., "High TNF-alpha and IL-8 levels predict low blood dendritic cell counts in primary cytomegalovirus infection", Journal of Clinical Virology, vol. 53, no. 4, pp. 360-363, 2012.
40. S. Hope, I. Melle, P. Aukrust et al., "Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor", Bipolar Disorders, vol. 11, no. 7, pp. 726-734, 2009.
41. A. Ortiz-Domínguez, M. E. Hernández, C. Berlanga et al., "Immune variations in bipolar disorder: phasic differences", Bipolar Disorders, vol. 9, no. 6, pp. 596-602, 2007.
42. A. H. Miller, "Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface", Brain, Behavior, and Immunity, vol. 23, no. 2, pp. 149-158, 2009.
43. A. H. Miller, V. Maletic, and C. L. Raison, "Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression", Biological Psychiatry, vol. 65, no. 9, pp. 732-741, 2009.
44. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki, "Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine", Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 22, pp. 12553-12558, 1996.
45. S. Okuda, N. Nishiyama, H. Saito, and H. Katsuki, "3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity", Journal of Neurochemistry, vol. 70, no. 1, pp. 299-307, 1998.
46. L. Brydon, N. A. Harrison, C. Walker, A. Steptoe, and H. D. Critchley, "Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans", Biological Psychiatry, vol. 63, no. 11, pp. 1022-1029, 2008.
47. L. Capuron, G. Pagnoni, M. Demetrashvili et al., "Anterior cingulate activation and error processing during interferonalpha treatment", Biological Psychiatry, vol. 58, no. 3, pp. 190-196, 2005.
48. N. A. Harrison, L. Brydon, C. Walker, M. A. Gray, A. Steptoe, and H. D. Critchley, "Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity", Biological Psychiatry, vol. 66, no. 5, pp. 407-414, 2009.
49. N. A. Harrison, L. Brydon, C. Walker et al., "Neural origins of human sickness in interoceptive responses to inflammation", Biological Psychiatry, vol. 66, no. 5, pp. 415-422, 2009.
50. A. R. Prossin, A. E. Koch, P. L. Campbell, M. G. McInnis, S. S. Zalcman, and J.-K. Zubieta, "Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers", Biological Psychiatry, vol. 69, no. 8, pp. 808-812, 2011.
51. C. L. Raison, R. Dantzer, K. W. Kelley et al., "CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression", Molecular Psychiatry, vol. 15, no. 4, pp. 393-403, 2010.